Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Ipamorelin's human data is limited to two published pharmacokinetic/pharmacodynamic studies: a 1999 PK/PD study (PMID: 10496658) that documented dose-response relationships and peak GH at 30-40 minutes post-injection in human volunteers, and a completed Phase II clinical trial for postoperative ileus (NCT00672074), after which ipamorelin's development for this indication was discontinued without approval
We also encourage our visitors the use of our online form
Injectable GHK-Cu is a different matter entirely
If GHK-Cu access is disrupted during the review, explore other anti-aging peptides and strategies
US$ 29.21
US$ 24.87
US$ 22.06
US$ 23.53
US$ 29.62
